SRC family kinases and receptors: analysis of three activation mechanisms by dynamic systems modeling.

Src family kinases (SFKs) interact with a number of cellular receptors. They participate in diverse signaling pathways and cellular functions. Most of the receptors involved in SFK signaling are characterized by similar modes of regulation. This computational study discusses a general kinetic model of SFK-receptor interaction. The analysis of the model reveals three major ways of SFK activation: release of inhibition by C-terminal Src kinase, weakening of the inhibitory intramolecular phosphotyrosine-SH2 interaction, and amplification of a stimulating kinase activity. The SFK model was then extended to simulate interaction with growth factor and T-cell receptors. The modular SFK signaling system was shown to adapt to the requirements of specific signaling contexts and yield qualitatively different responses in the different simulated environments. The model also provides a systematic overview of the major interactions between SFKs and various cellular signaling systems and identifies their common properties.

[1]  Jayajit Das,et al.  Sensitivity of T cells to antigen and antagonism emerges from differential regulation of the same molecular signaling module , 2007, Proceedings of the National Academy of Sciences.

[2]  Sheraz Yaqub,et al.  Release from Tonic Inhibition of T Cell Activation through Transient Displacement of C-terminal Src Kinase (Csk) from Lipid Rafts* , 2001, The Journal of Biological Chemistry.

[3]  S. Courtneidge,et al.  Src family tyrosine kinases and growth factor signaling. , 2000, Experimental cell research.

[4]  T. Boggon,et al.  Structure and regulation of Src family kinases , 2004, Oncogene.

[5]  D. Lauffenburger,et al.  Receptors: Models for Binding, Trafficking, and Signaling , 1993 .

[6]  T. Hunter,et al.  The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding , 1997, Oncogene.

[7]  T. Yagi,et al.  Constitutive activation of Src family kinases in mouse embryos that lack Csk , 1993, Cell.

[8]  R. Klausner,et al.  Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Werner Dubitzky,et al.  Bistable switching and excitable behaviour in the activation of Src at mitosis , 2006, ISMB.

[10]  Toshifumi Takao,et al.  Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases , 2000, Nature.

[11]  J. Downward,et al.  Autophosphorylation sites on the epidermal growth factor receptor , 1984, Nature.

[12]  B. Schraven,et al.  PAG-Associated FynT Regulates Calcium Signaling and Promotes Anergy in T Lymphocytes , 2007, Molecular and Cellular Biology.

[13]  H. Metzger,et al.  An unusual mechanism for ligand antagonism. , 1998, Science.

[14]  E. J. Doedel,et al.  AUTO: a program for the automatic bifurcation analysis of autonomous systems , 1980 .

[15]  S. Harrison,et al.  Crystal structures of c-Src reveal features of its autoinhibitory mechanism. , 1999, Molecular cell.

[16]  Werner Dubitzky,et al.  Deactivation of Src Family Kinases: Hypothesis Testing Using a Monte Carlo Sensitivity Analysis of Systems-Level Properties , 2007, J. Comput. Biol..

[17]  T. Kmiecik,et al.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation , 1987, Cell.

[18]  Arthur Weiss,et al.  Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation , 2004, Oncogene.

[19]  A. Ullrich,et al.  Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation , 2006, Oncogene.

[20]  T. Hunter,et al.  Phosphorylation of receptor protein‐tyrosine phosphatase alpha on Tyr789, a binding site for the SH3‐SH2‐SH3 adaptor protein GRB‐2 in vivo. , 1994, The EMBO journal.

[21]  P. De,et al.  CSK negatively regulates nerve growth factor induced neural differentiation and augments AKT kinase activity. , 2005, Experimental cell research.

[22]  Bernhard Hemmer,et al.  TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways , 2003, Nature Immunology.

[23]  Tomas Mustelin,et al.  Activation of the Cooh-Terminal Src Kinase (Csk) by Camp-Dependent Protein Kinase Inhibits Signaling through the T Cell Receptor , 2001, The Journal of experimental medicine.

[24]  N. Lydon,et al.  Cdc2-mediated modulation of pp60c-src activity. , 1994, Journal of Biological Chemistry.

[25]  P. Furet,et al.  Modulation of the SH2 Binding Specificity and Kinase Activity of Src by Tyrosine Phosphorylation within Its SH2 Domain (*) , 1996, The Journal of Biological Chemistry.

[26]  B. Neel,et al.  The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. , 2003, Trends in biochemical sciences.

[27]  J. Tyson,et al.  The dynamics of cell cycle regulation. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[28]  Stevan R. Hubbard,et al.  Src autoinhibition: let us count the ways , 1999, Nature Structural Biology.

[29]  V. Horejsi,et al.  Phosphorylation-Dependent Regulation of T-Cell Activation by PAG/Cbp, a Lipid Raft-Associated Transmembrane Adaptor , 2003, Molecular and Cellular Biology.

[30]  Satoru Takeuchi,et al.  Structure of the Carboxyl-terminal Src Kinase, Csk* , 2002, The Journal of Biological Chemistry.

[31]  K. Taskén,et al.  Combined Spatial and Enzymatic Regulation of Csk by cAMP and Protein Kinase A Inhibits T Cell Receptor Signaling* , 2003, The Journal of Biological Chemistry.

[32]  S. Nada,et al.  Mechanism of Csk-mediated Down-regulation of Src Family Tyrosine Kinases in Epidermal Growth Factor Signaling* , 2004, Journal of Biological Chemistry.

[33]  A. Kazlauskas,et al.  A Role for Src in Signal Relay by the Platelet-derived Growth Factor α Receptor* , 1998, The Journal of Biological Chemistry.

[34]  S. Levin,et al.  Regulation of Fyn Through Translocation of Activated Lck into Lipid Rafts , 2003, The Journal of experimental medicine.

[35]  M. Okada,et al.  Cutting Edge: Transmembrane Phosphoprotein Csk-Binding Protein/Phosphoprotein Associated With Glycosphingolipid-Enriched Microdomains as a Negative Feedback Regulator of Mast Cell Signaling Through the FcεRI , 2002, The Journal of Immunology.

[36]  J. S. Griffith,et al.  Mathematical neurobiology: An introduction to the mathematics of the nervous system , 1971 .

[37]  M. Maa,et al.  c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function* , 1999, The Journal of Biological Chemistry.

[38]  T. McKeithan,et al.  Kinetic proofreading in T-cell receptor signal transduction. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Kholodenko,et al.  Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[40]  Karel Drbal,et al.  Phosphoprotein Associated with Glycosphingolipid-Enriched Microdomains (Pag), a Novel Ubiquitously Expressed Transmembrane Adaptor Protein, Binds the Protein Tyrosine Kinase Csk and Is Involved in Regulation of T Cell Activation , 2000, The Journal of experimental medicine.

[41]  T. Mustelin,et al.  A Weak Lck Tail Bite Is Necessary for Lck Function in T Cell Antigen Receptor Signaling* , 2007, Journal of Biological Chemistry.